Cargando…
Pretreatment With PCSK9 Inhibitor Protects the Brain Against Cardiac Ischemia/Reperfusion Injury Through a Reduction of Neuronal Inflammation and Amyloid Beta Aggregation
BACKGROUND: Cardiac ischemic/reperfusion (I/R) injury leads to brain damage. A new antihyperlipidemic drug is aimed at inhibiting PCSK9 (proprotein convertase subtilisin/kexin type 9), a molecule first identified in a neuronal apoptosis paradigm. Thus, the PCSK9 inhibitor (PCSK9i) may play a role in...
Autores principales: | Apaijai, Nattayaporn, Moisescu, Dalila Monica, Palee, Siripong, McSweeney, Christian Mervyn, Saiyasit, Napatsorn, Maneechote, Chayodom, Boonnag, Chiraphat, Chattipakorn, Nipon, Chattipakorn, Siriporn C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6497363/ https://www.ncbi.nlm.nih.gov/pubmed/30636486 http://dx.doi.org/10.1161/JAHA.118.010838 |
Ejemplares similares
-
PCSK9 inhibitor improves cardiac function and reduces infarct size in rats with ischaemia/reperfusion injury: Benefits beyond lipid‐lowering effects
por: Palee, Siripong, et al.
Publicado: (2019) -
Roles of mitochondrial dynamics modulators in cardiac ischaemia/reperfusion injury
por: Maneechote, Chayodom, et al.
Publicado: (2017) -
Combined Vildagliptin and Metformin Exert Better Cardioprotection than Monotherapy against Ischemia-Reperfusion Injury in Obese-Insulin Resistant Rats
por: Apaijai, Nattayaporn, et al.
Publicado: (2014) -
Effects of d‐galactose‐induced ageing on the heart and its potential interventions
por: Bo‐Htay, Cherry, et al.
Publicado: (2018) -
Acute dapagliflozin administration exerts cardioprotective effects in rats with cardiac ischemia/reperfusion injury
por: Lahnwong, Sarayut, et al.
Publicado: (2020)